Repare Therapeutics Inc. Operating Lease Right-of-Use Assets
Repare Therapeutics Inc. had Operating Lease Right-of-Use Assets of $0 as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-11-14
- 2025-09-30: Operating Lease, Right-of-Use Asset $0.00.
- 2025-06-30: Operating Lease, Right-of-Use Asset $629.00K.
- 2025-03-31: Operating Lease, Right-of-Use Asset $1.36M.
- 2024-12-31: Operating Lease, Right-of-Use Asset $1.92M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 |
| 2025-06-30 | $629.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $1.36M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $1.92M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $2.47M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.19M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $2.76M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $3.33M 10-K · filed 2025-03-03 |
| 2023-09-30 | $3.88M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.43M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $4.98M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $5.37M 10-K · filed 2024-02-28 |
| 2022-09-30 | $5.90M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $6.46M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $7.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $7.49M 10-K · filed 2023-02-28 |
| 2021-09-30 | $7.25M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $4.63M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $4.30M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $4.67M 10-K · filed 2022-03-01 |
| 2020-09-30 | $5.02M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $729.00K 10-Q · filed 2020-08-13 |
| 2019-12-31 | $1.03M 10-K · filed 2021-03-04 |